G01N 2800/065
Bowel diseases
Official title: Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
G01N2800/065 (Bowel diseases) appears on 388 US grants and 796 published applications in this corpus.
Search patents in G01N- Granted patents
- 388
- Published applications
- 796
- Assignees
- 344
- Inventors
- 1,304
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 6 |
| 2003 | 1 | 8 |
| 2004 | 4 | 21 |
| 2005 | 1 | 12 |
| 2006 | 7 | 29 |
| 2007 | 6 | 26 |
| 2008 | 9 | 22 |
| 2009 | 16 | 31 |
| 2010 | 11 | 35 |
| 2011 | 20 | 24 |
| 2012 | 11 | 32 |
| 2013 | 16 | 32 |
| 2014 | 12 | 27 |
| 2015 | 10 | 34 |
| 2016 | 14 | 42 |
| 2017 | 24 | 44 |
| 2018 | 32 | 54 |
| 2019 | 30 | 49 |
| 2020 | 36 | 54 |
| 2021 | 25 | 40 |
| 2022 | 24 | 50 |
| 2023 | 16 | 33 |
| 2024 | 21 | 41 |
| 2025 | 18 | 23 |
| 2026 | 11 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Metabolic biomarkers of inflammatory bowel disease6 Oct 2026US 12,754,192 B2Institut de Cardiologie de Montreal
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases7 Jul 2026US 12,673,974 B2Protagonist Therapeutics, Inc.
- Methods of monitoring inflammatory bowel diseases9 Jun 2026US 12,650,434 B2Icahn School of Medicine at Mount Sinai
- Compositions and methods for treating inflammatory bowel disease2 Jun 2026US 12,642,819 B2Icahn School of Medicine at Mount Sinai
- Methods of diagnosing inflammatory bowel disease through RNASET25 May 2026US 12,618,111 B2Cedars-Sinai Medical Center
- C3-HNE Assay8 Oct 2026US 2026/0309721 A1Nordic Bioscience A/S
- Predicting non-responsiveness of ibd patients1 Oct 2026US 2026/0298945 A1Navolab Diagnosztika Kft.
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases24 Sep 2026US 2026/0285908 A1Protagonist Therapeutics, Inc.
- Method for determining intestinal permeability17 Sep 2026US 2026/0276634 A1Biomedal, S.L.
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
Most cited
By later US patents
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens96US 6,033,864 AThe Regents of the University of California · 2000
- Methods of treating diarrhea caused by small intestinal bacterial overgrowth81US 7,935,799 B2Cedars-Sinai Medical Center · 2011
- Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth76US 8,197,805 B2Cedars-Sinai Medical Center · 2012
- Methods of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth75US 6,805,852 B2Cedars-Sinai Medical Center · 2004